Evidence map›Paper›PMID 19586156›Full record

ArticlePsychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors2009

Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment.

Lisa M Fucito, Benjamin A Toll, Peter Salovey, Stephanie S O'Malley

Registry-linked trialAbstract read
In one paragraph

Article in Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05997901 (Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05997901 nacompletednot on this mapstarted 2024, after this paper: background citation

Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study

TypeinterventionalSponsorCentre for Addiction and Mental HealthRan2024 to 2025Enrolled40ConditionsMedication Adherence, Smoking CessationArmsVarenicline healthbot
3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. A Pilot Randomized Clinical Trial of Remote Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Correlates of Adherence to Varenicline Among HIV+ Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Trial
  6. Trial
  7. Factors associated with discontinuation of bupropion and counseling among African American light smokers in a randomized clinical trial.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2013
    Trial
  8. Adherence to varenicline in the COMPASS smoking cessation intervention trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2011
    Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Adherence to Pharmacological Smoking Cessation Interventions: A Literature Review and Synthesis of Correlates and Barriers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lisa M FucitoDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT 06511, USA. lisa.fucito@yale.edu
Benjamin A Toll
Peter Salovey
Stephanie S O'Malley

Funding

SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Tobacco Dependence &Risk Factors for Treatment FailureP50AA015632 · NIAAA · YALE UNIVERSITY · PI MAKUCH, ROBERT W. · 2004 to 2008
$9.2M
TOBACCO DEPENDENCE AND RISK FACTORS FOR TREATMENT FAILURP50DA013334 · NIDA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 1999 to 2003
$8.0M
PROMOTING CANCER PREVENTION/CONTROL WITH MESSAGE FRAMINGR01CA068427 · NCI · YALE UNIVERSITY · PI SALOVEY, PETER · 1997 to 2011
$4.6M
Improving Alcoholism TreatmentK05AA014715 · NIAAA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 2004 to 2013
$2.1M
Translational Neuroscience Research in Alcoholism (TNRA-TP)T32AA015496 · NIAAA · YALE UNIVERSITY · PI PETRAKIS, ISMENE L. · 2005 to 2014
$1.6M
Resident/Intern Substance Use Research Education (REINSURE)R25DA020515 · NIDA · YALE UNIVERSITY · PI BALL, SAMUEL A. · 2006 to 2012
$1.1M
NCI NIH HHS R01 CA068427NIAAA NIH HHS K05 AA014715NIAAA NIH HHS K05-AA014715NIAAA NIH HHS L30 AA018621NIAAA NIH HHS P50 AA015632NIAAA NIH HHS P50-AA15632NIAAA NIH HHS T32-AA015496NIDA NIH HHS K12 DA000167NIDA NIH HHS K12-DA000167NIDA NIH HHS P50 DA013334NIDA NIH HHS P50-DA13334NIDA NIH HHS R25 DA020515NIDA NIH HHS R25-DA020515
6 · The paper itself

Abstract

Beliefs about medication are associated with treatment adherence and outcome. This is a secondary analysis of the role of beliefs and attitudes about bupropion in treatment adherence and smoking cessation outcomes using data from a smoking cessation trial of open-label sustained-release (SR) bupropion therapy reported previously (Toll et al., 2007). Positive beliefs and attitudes were positively correlated with intentions, desire, confidence, and motivation to quit smoking; expectation of quitting success; perceived benefits of quitting; and perceived disadvantages of smoking. Positive beliefs were also associated with greater medication adherence, an increased likelihood of completing treatment and being continuously abstinent, and a delayed latency to smoking lapse. These findings provide preliminary support that positive beliefs and attitudes about bupropion are associated with positive attitudes toward quitting, better treatment adherence, and potentially better treatment response.

Indexed as

Health Knowledge, Attitudes, PracticeAdultAntidepressive Agents, Second-GenerationBupropionDrug MonitoringFemaleHumansIntentionMaleMedication AdherenceMiddle AgedMotivationSmoking CessationSurveys and QuestionnairesTobacco Use DisorderTreatment OutcomeAntidepressive Agents, Second-GenerationBupropion

Identifiers

PMID19586156
PMCPMC3094849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.